Skip to main content

All Access Subscription

Get unlimited access to our full publication and article library.

Get Access Now

Interested in Group Sales? Learn more

A randomized, double-blind, placebo-controlled trial of short-course dexamethasone therapy as an adjunct to antimicrobial therapy was conducted among children 3 months to 11 years of age with hematogenous suppurative arthritis in Costa Rica from 1998 to 2000.

Adjunct Dexamethasone Therapy for Hematogenous Suppurative Arthritis